health
NHS Expands Genetic Testing to Protect Minority Ethnic Cancer Patients
NHS England now tests for a fifth DPYD gene variant before chemotherapy, correcting a historic gap that left Black and minority ethnic patients at higher risk of fatal side effects.
HIGH confidence
Black and minority ethnic cancer patients previously faced higher risk of severe or fatal chemotherapy reactions due to genetic tests not designed to detect variants in their DNA.
Coverage (0 articles)
No articles in this topic yet.